ribociclib
novartis
['breast', 'ribociclib']
ribociclib + endocrine therapy significantly improves invasive disease-free survival in patients with early hr +ve/her2 negative breast cancer 
Professor of Medical Oncology,  Amrita Institute of Medical  Sciences. Oncologist and Hematologist